Some 20% of people with axial spondyloarthritis (axSpA) included in a prospective cohort study showed no lesions in their ...

Sclerotic lesions can be malignant or benign. They are usually localized to a single bone or area of your body. A malignant lesion is often cancerous, posing a risk to your health if it is not treated ...

—In a new study, the extent of microstructural damage in patients with early relapsing-remitting multiple sclerosis (RRMS) was associated with worse disability and spinal cord atrophy at 5 years. Here ...

Even with disease-modifying therapies, patients who have chronically active inflammatory MS lesions can expect an aggressive disease course and poor outcomes. A new study shows that patients with ≥4 ...

Using advanced methodology, scientists have been able to reveal at the cellular level how lesions in multiple sclerosis develop. Using advanced methodology, scientists in Sweden were able to reveal at ...

In contrast to traditional measures, such as an increase or worsening of lesions or overall brain atrophy, to signal progression of multiple sclerosis (MS), investigators are proposing atrophied ...

Using advanced methodology, scientists in Sweden were able to reveal at the cellular level how lesions in multiple sclerosis develop. The new results are presented in the journal Cell by researchers ...

A 29 year-old woman presented with loss of coordination affecting the right arm and leg. Multiple Sclerosis (MS): (Left and Middle) Flair axial MRIs; (Right) T1-weighted with gadolinium (GAD) axial ...

A 35 year-old man with multiple sclerosis had a history of 1-2 attacks every year. Multiple Sclerosis (MS): Flair axial MRIs. Note the numerous demyelinating lesions in multiple areas of the white ...

The diagnostic criteria for MS reflect a growing understanding of the condition and the application of new advancements in medical technology to help improve diagnostic accuracy and reliability.